Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin

Overview of attention for article published in Cardiovascular Diabetology, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 4 X users, with an upper bound of 2,672 followers.

RT @Manugrillo2: Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving #r…

28 Oct 2021

Reply Repost Favourite

RT @Manugrillo2: Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving #r…

27 Oct 2021

Reply Repost Favourite

RT @Manugrillo2: Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving #r…

27 Oct 2021

Reply Repost Favourite

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving #rivaroxaban or warfarin https://t.co/0nDk1FyjrO

27 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.